Delivery Order SPE2DB22D3301-SPE2DB25FY4LE
Award Date
5/7/25
Potential Completion Date
5/8/25
Potential Value
$4.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,018.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,567,967,900 units of the prescription medication Vyvanse 70 mg capsules. The contract is a delivery order, with a firm fixed price and an ultimate completion date of April 21, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award, valued at $4,788.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,072,761 units of the prescription medication Vyvanse 30 mg capsules. The award is a delivery order contract with a firm fixed price and an ultimate completion date of April 29, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award, valued at $1,337.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of 4,568,013,823 units of the prescription medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of April 24, 2025 and is a firm fixed price arrangement. It is not designated as a set-aside contract, indicating open...
This federal contract award is a $1,075.66 delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,392 units of the prescription medication Vyvanse 30 mg capsule. The contract has an ultimate completion date of August 9, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $2,670.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,058,061 units of the medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of April 29, 2025 and is a firm fixed-price contract. This contract award is not associated with a set-aside program. Amerisourcebergen...
This federal contract award, valued at $1,111.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,060,858 units of the medication Vyvanse 10 mg capsules. This is a firm fixed-price delivery order contract with an ultimate completion date of April 29, 2025. The award does not utilize any set-aside designations, indicating open competition....
This federal contract award, valued at $4,403.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,165,601 units of the prescription medication Vyvanse 30 mg capsules. The contract has a firm fixed price and an ultimate completion date of May 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,601.72 Firm Fixed Price delivery order contract is for the supply of 4,565,056,712 units of the prescription medication Vyvanse 50 mg capsules. The contract has a period of performance through July 2, 2024. This award is associated with AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $2,261.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,409,330 units of the prescription medication Vyvanse 20 mg capsules. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at...
This federal contract award, valued at $3,507.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,555,791,203 units of the prescription drug Vyvanse 40 mg capsules. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...